Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2000
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits ; day:21 ; month:6 ; year:2017 ; pages:1-9
Molecular diagnosis & therapy ; (21.6.2017), 1-9
- Keyword
-
Krebs
Onkologie
- Creator
-
Ma, Wanlong
- Contributor
-
Brodie, Steven
Agersborg, Sally
Funari, Vincent A.
Albitar, Maher
SpringerLink (Online service)
- DOI
-
10.1007/s40291-017-0290-z
- URN
-
urn:nbn:de:1111-201709119540
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ma, Wanlong
- Brodie, Steven
- Agersborg, Sally
- Funari, Vincent A.
- Albitar, Maher
- SpringerLink (Online service)
Other Objects (12)
FDA-cleared home sleep apnea testing devices
Levels of autonomy in FDA-cleared surgical robots: a systematic review
KRAS- und BRAF-Mutationen im lokal fortgeschrittenen Rektumkarzinom
KRAS and BRAF mutational status in colon cancer from Albanian patients
Vergleich des KRAS/BRAF-Mutationsstatus zwischen Primärtumoren und Metastasen kolorektaler Karzinome
The clinician-AI interface: intended use and explainability in FDA-cleared AI devices for medical image interpretation
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Survival kits
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
FDA
FDA-cleared home sleep apnea testing devices
Levels of autonomy in FDA-cleared surgical robots: a systematic review
KRAS- und BRAF-Mutationen im lokal fortgeschrittenen Rektumkarzinom
KRAS and BRAF mutational status in colon cancer from Albanian patients
Vergleich des KRAS/BRAF-Mutationsstatus zwischen Primärtumoren und Metastasen kolorektaler Karzinome
The clinician-AI interface: intended use and explainability in FDA-cleared AI devices for medical image interpretation
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Survival kits
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
FDA
FDA-cleared home sleep apnea testing devices
Levels of autonomy in FDA-cleared surgical robots: a systematic review
KRAS- und BRAF-Mutationen im lokal fortgeschrittenen Rektumkarzinom
KRAS and BRAF mutational status in colon cancer from Albanian patients
Vergleich des KRAS/BRAF-Mutationsstatus zwischen Primärtumoren und Metastasen kolorektaler Karzinome
The clinician-AI interface: intended use and explainability in FDA-cleared AI devices for medical image interpretation
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Survival kits
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants